目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Anti-infective Vaccines Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Market Driving Factors
3.3.1 Rising Focus and Government Support on Immunization Programs
3.3.2 Growing Investment in Vaccine Development
3.3.3 Increasing Company Initiatives to Enhance Vaccine R&D
3.3.4 High Prevalence of Infectious Diseases
3.3.5 Technological Advancements in Vaccine Administration
3.3.6 Strong Supply Backed Up by Robust R&D to Drive the Market
3.4 Market Restraining Factors
3.4.1 Inadequate Reimbursement Coverage
3.4.2 High Cost of Vaccine Development
3.4.3 Extended Timelines of Vaccine Manufacturing Hinder the Growth of the Vaccines Market
3.4.4 Stringent Government Regulations for Approval
3.4.5 Inadequate Access to Vaccines
3.5 Opportunities in the Global Market
3.5.1 High Growth Prospects in Emerging Markets
3.5.2 Focus on Therapeutic Vaccines
3.5.3 Use of Adjuvants in Vaccines
3.5.4 Government Support for Future Vaccine R&D
3.6 COVID-19 Impact Analysis
3.7 Porter’s Five Forces Analysis
3.7.1 Bargaining Power of Buyers: Low to Medium
3.7.2 Bargaining Power of Suppliers: High
3.7.3 Competitive Rivalry: Low to Medium
3.7.4 Threat of New Entrants: Low to Medium
3.7.5 Threat of Substitutes: Low
3.8 PEST Analysis

4 Global Anti-infective Vaccines Market Analysis by Disease Type
4.1 Key Findings
4.2 Disease Type Segment Growth Prospects
4.3 Global Anti-infective Vaccines Market Size Estimation and Forecast by Disease Type
4.4 Bacterial Diseases
4.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.4.2 Market Share by Region, 2022 & 2032 (%)
4.5 Viral Diseases
4.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
4.5.2 Market Share by Region, 2022 & 2032 (%)

5 Global Anti-infective Vaccines Market Analysis by Product
5.1 Key Findings
5.2 Product Segment Growth Prospects
5.3 Global Anti-infective Vaccines Market Size Estimation and Forecast by Product
5.4 Live/Attenuated Vaccines
5.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 Inactivated Vaccines
5.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Market Share by Region, 2022 & 2032 (%)
5.6 DNA & Recombinant Vector Vaccines
5.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 Market Share by Region, 2022 & 2032 (%)
5.7 Others
5.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.7.2 Market Share by Region, 2022 & 2032 (%)

6 Global Anti-infective Vaccines Market Analysis by Distribution Channel
6.1 Key Findings
6.2 Distribution Channel Segment Growth Prospects
6.3 Global Anti-infective Vaccines Market Size Estimation and Forecast by Distribution Channel
6.4 Hospital Pharmacy
6.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.5 Retail Pharmacy
6.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Market Share by Region, 2022 & 2032 (%)
6.6 Others
6.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.6.2 Market Share by Region, 2022 & 2032 (%)

7 Global Anti-infective Vaccines Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
7.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

8 North America Anti-infective Vaccines Market Analysis
8.1 Key Findings
8.2 North America Anti-infective Vaccines Market Attractiveness Index
8.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
8.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
8.5 Market Size Estimation and Forecast by Disease Type, 2022-2032 (US$ Mn)
8.5.1 Market Size Estimation and Forecast by Bacterial Diseases
8.5.2 Market Size Estimation and Forecast by Viral Diseases
8.6 Market Size Estimation and Forecast by Product, 2022-2032 (US$ Mn)
8.7 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ Mn)
8.8 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
8.8.1 U.S.
8.8.2 Canada

9 Europe Anti-infective Vaccines Market Analysis
9.1 Key Findings
9.2 Europe Anti-infective Vaccines Market Attractiveness Index
9.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
9.5 Market Size Estimation and Forecast by Disease Type, 2022-2032 (US$ Mn)
9.5.1 Market Size Estimation and Forecast by Bacterial Diseases
9.5.2 Market Size Estimation and Forecast by Viral Diseases
9.6 Market Size Estimation and Forecast by Product, 2022-2032 (US$ Mn)
9.7 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ Mn)
9.8 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
9.8.1 Germany
9.8.2 UK
9.8.3 France
9.8.4 Italy
9.8.5 Spain
9.8.6 Russia
9.8.7 Rest of Europe

10 Asia Pacific Anti-infective Vaccines Market Analysis
10.1 Key Findings
10.2 Asia Pacific Anti-infective Vaccines Market Attractiveness Index
10.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
10.5 Market Size Estimation and Forecast by Disease Type, 2022-2032 (US$ Mn)
10.5.1 Market Size Estimation and Forecast by Bacterial Diseases
10.5.2 Market Size Estimation and Forecast by Viral Diseases
10.6 Market Size Estimation and Forecast by Product, 2022-2032 (US$ Mn)
10.7 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ Mn)
10.8 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
10.8.1 Japan
10.8.2 China
10.8.3 India
10.8.4 Australia
10.8.5 Rest of Asia Pacific

11 Latin America Anti-infective Vaccines Market Analysis
11.1 Key Findings
11.2 Latin America Anti-infective Vaccines Market Attractiveness Index
11.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
11.5 Market Size Estimation and Forecast by Disease Type, 2022-2032 (US$ Mn)
11.5.1 Market Size Estimation and Forecast by Bacterial Diseases
11.5.2 Market Size Estimation and Forecast by Viral Diseases
11.6 Market Size Estimation and Forecast by Product, 2022-2032 (US$ Mn)
11.7 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ Mn)
11.8 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
11.8.1 Brazil
11.8.2 Mexico
11.8.3 Rest of Latin America

12 MEA Anti-infective Vaccines Market Analysis
12.1 Key Findings
12.2 MEA Anti-infective Vaccines Market Attractiveness Index
12.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
12.5 Market Size Estimation and Forecast by Disease Type, 2022-2032 (US$ Mn)
12.5.1 Market Size Estimation and Forecast by Bacterial Diseases
12.5.2 Market Size Estimation and Forecast by Viral Diseases
12.6 Market Size Estimation and Forecast by Product, 2022-2032 (US$ Mn)
12.7 Market Size Estimation and Forecast by Distribution Channel, 2022-2032 (US$ Mn)
12.8 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
12.8.1 GCC
12.8.2 South Africa
12.8.3 Rest of MEA

13 Company Profiles
13.1 AstraZeneca PLC.
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2016-2021
13.1.3.2 Regional Market Shares, 2021
13.1.3.3 Gross Profit, 2016-2021
13.1.3.4 R&D, 2016-2021
13.1.4 Product Benchmarking
13.1.5 Strategic Outlook
13.2 Bavarian Nordic
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2016-2021
13.2.3.2 Regional Market Shares, 2021
13.2.3.3 Gross Profit, 2016-2021
13.2.3.4 R&D, 2016-2021
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 BioDiem
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 CSL Limited
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2016-2021
13.4.3.2 Regional Market Shares, 2021
13.4.3.3 Gross Profit, 2016-2021
13.4.3.4 R&D, 2016-2021
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Emergent BioSolutions Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2016-2021
13.5.3.2 Gross Profit, 2016-2021
13.5.3.3 R&D, 2016-2021
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 Evotec
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2016-2021
13.6.3.2 Regional Market Shares, 2021
13.6.3.3 Gross Profit, 2016-2021
13.6.3.4 R&D, 2016-2021
13.6.4 Product Benchmarking
13.6.5 Strategic Outlook
13.7 Merck & Co, Inc.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2016-2021
13.7.3.2 Regional Market Shares, 2021
13.7.3.3 Gross Profit, 2016-2021
13.7.3.4 R&D, 2016-2021
13.7.4 Product Benchmarking
13.7.5 Strategic Outlook
13.8 Mitsubishi Tanabe Pharma Corporation
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.8.4 Strategic Outlook
13.9 Pfizer
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2016-2021
13.9.3.2 Regional Market Shares, 2021
13.9.3.3 Gross Profit, 2016-2021
13.9.3.4 R&D, 2016-2021
13.9.4 Product Benchmarking
13.9.5 Strategic Outlook
13.10 Serum Institute of India Pvt. Ltd.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.10.4 Strategic Outlook
13.11 Sinovac Biotech Ltd.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2016-2021
13.11.3.2 Gross Profit, 2016-2021
13.11.3.3 R&D, 2016-2021
13.11.4 Product Benchmarking
13.12 Valneva SE
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2016-2021
13.12.4 Product Benchmarking
13.12.5 Strategic Outlook

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

List of Tables
Table 1 Global Anti-infective Vaccines Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Global Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 7 Bacterial Diseases Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 8 Viral Diseases Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 9 Global Anti-infective Vaccines Market Forecast by Product Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 10 Live/Attenuated Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 11 Major Whole Inactivated Virus COVID-19 Vaccine
Table 12 Inactivated Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 13 DNA Vaccines for Global COVID-19: Global Status
Table 14 DNA & Recombinant Vector Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 15 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 16 Global Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 17 Hospital Pharmacy Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 18 Retail Pharmacy Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 19 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 20 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR %)
Table 21 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "V" Shaped Recovery
Table 22 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "U" Shaped Recovery
Table 23 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "W" Shaped Recovery
Table 24 Global Anti-infective Vaccines Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%): "L" Shaped Recovery
Table 25 North America Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 26 North America Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 27 North America Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 28 North America Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 29 North America Anti-infective Vaccines Market Forecast by Product Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 30 North America Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 31 U.S Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 32 Canada Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 33 Europe Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 34 Europe Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 35 Europe Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 36 Europe Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 37 Europe Anti-infective Vaccines Market Forecast by Product Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 38 Europe Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 39 Germany Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 40 UK Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 41 France Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 42 Italy Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 43 Spain Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 44 Russia Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 45 Rest of Europe Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 46 Asia Pacific Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 47 Asia Pacific Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 48 Asia Pacific Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 49 Asia Pacific Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 50 Asia Pacific Anti-infective Vaccines Market Forecast by Product Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 51 Asia Pacific Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 52 Japan Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 53 China Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 54 India Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 55 Australia Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 56 Rest of Asia Pacific Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 57 Latin America Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 58 Latin America Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 59 Latin America Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 60 Latin America Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 61 Latin America Anti-infective Vaccines Market Forecast by Product Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 62 Latin America Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 63 Brazil Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 64 Mexico Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 65 Rest of Latin America Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 66 MEA Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 67 MEA Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 68 MEA Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 69 MEA Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million, AGR%, CAGR %)
Table 70 MEA Anti-infective Vaccines Market Forecast by Product Type, 2022-2032 (US$ million, AGR%, CAGR %)
Table 71 MEA Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million, AGR%, CAGR %)
Table 72 GCC Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 73 South Africa Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 74 MEA Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR %)
Table 75 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 AstraZeneca: Product Benchmarking
Table 77 AstraZeneca: Strategic Outlook
Table 78 Bavarian Nordic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Bavarian Nordic: Product Benchmarking
Table 80 Bavarian Nordic: Strategic Outlook
Table 81 BioDiem: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 BioDiem: Product Benchmarking
Table 83 CSL Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 CSL Limited: Product Benchmarking
Table 85 CSL Limited: Strategic Outlook
Table 86 Emergent BioSolutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Emergent BioSolutions Inc.: Product Benchmarking
Table 88 Emergent BioSolutions Inc.: Strategic Outlook
Table 89 Evotec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Evotec: Product Benchmarking
Table 91 Evotec: Strategic Outlook
Table 92 Merck & Co, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Merck & Co, Inc.: Product Benchmarking
Table 94 Merck & Co, Inc.: Strategic Outlook
Table 95 Mitsubishi Tanabe Pharma Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Mitsubishi Tanabe Pharma Corporation: Product Benchmarking
Table 97 Mitsubishi Tanabe Pharma Corporation: Strategic Outlook
Table 98 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Pfizer: Product Benchmarking
Table 100 Pfizer: Strategic Outlook
Table 101 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Serum Institute of India Pvt. Ltd.: Product Benchmarking
Table 103 Serum Institute of India Pvt. Ltd.: Strategic Outlook
Table 104 Sinovac Biotech Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Sinovac Biotech Ltd.: Product Benchmarking
Table 106 Valneva SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Valneva SE: Product Benchmarking
Table 108 Valneva SE: Strategic Outlook
?

List of Figures
Figure 1 Global Anti-infective Vaccines Market Segmentation
Figure 2 Global Anti-infective Vaccines Market Attractiveness Index by Region
Figure 3 Global Anti-infective Vaccines Market by Disease Type: Market Attractiveness Index
Figure 4 Global Anti-infective Vaccines Market by Product: Market Attractiveness Index
Figure 5 Global Anti-infective Vaccines Market by Distribution Channel: Market Attractiveness Index
Figure 6 Global Anti-infective Vaccines Market: Market Dynamics
Figure 7 Global COVID Impact Analysis: Anti-infective Vaccines Market Recovery Scenarios
Figure 8 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Global Anti-infective Vaccines Market: Porter’s Five Forces Analysis
Figure 13 Global Anti-infective Vaccines Market: PEST Analysis
Figure 14 Global Anti-infective Vaccines Market Attractiveness Index by Disease Type
Figure 15 Global Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million)
Figure 16 Global Anti-infective Vaccines Market Share Forecast by Disease Type, 2022, 2027, 2032 (%)
Figure 17 Bacterial Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 18 Bacterial Diseases Market Share Forecast by Region, 2022 & 2032 (%)
Figure 19 Viral Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 20 Viral Diseases Market Share Forecast by Region, 2022 & 2032 (%)
Figure 21 Global Anti-infective Vaccines Market Attractiveness Index by Disease Type
Figure 22 Global Anti-infective Vaccines Market Forecast by Product, 2022-2032 (US$ million)
Figure 23 Global Anti-infective Vaccines Market Share Forecast by Product, 2022, 2027, 2032 (%)
Figure 24 Live/Attenuated Vaccines Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 Live/Attenuated Vaccines Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Inactivated Vaccines Market Forecast by Region, 2022-2032 (US$ million)
Figure 27 Inactivated Vaccines Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 DNA & Recombinant Vector Vaccines Market Forecast by Region, 2022-2032 (US$ million)
Figure 29 DNA & Recombinant Vector Vaccines Market Share Forecast by Region, 2022 & 2032 (%)
Figure 30 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 31 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 32 Global Anti-infective Vaccines Market Attractiveness Index by Distribution Channel
Figure 33 Global Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million)
Figure 34 Global Anti-infective Vaccines Market Share Forecast by Distribution Channel, 2022, 2027, 2032 (%)
Figure 35 Hospital Pharmacy Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 Hospital Pharmacy Market Share Forecast by Region, 2022 & 2032 (%)
Figure 37 Retail Pharmacy Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Retail Pharmacy Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Global Anti-infective Vaccines Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR %)
Figure 42 Global Anti-infective Vaccines Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 43 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Figure 44 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 45 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 46 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 47 Global Anti-infective Vaccines Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 48 North America Anti-infective Vaccines Market Attractiveness Index
Figure 49 North America Anti-infective Vaccines Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 50 North America Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million)
Figure 51 North America Anti-infective Vaccines Market Share Forecast by Country, 2022 & 2032 (%)
Figure 52 North America Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million)
Figure 53 North America Anti-infective Vaccines Market Share Forecast by Disease Type, 2022 & 2032 (%)
Figure 54 North America Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million)
Figure 55 North America Anti-infective Vaccines Market Share Forecast by Bacterial Diseases, 2022 & 2032 (%)
Figure 56 North America Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million)
Figure 57 North America Anti-infective Vaccines Market Share Forecast by Viral Diseases, 2022 & 2032 (%)
Figure 58 North America Anti-infective Vaccines Market Forecast by Product, 2022-2032 (US$ million)
Figure 59 North America Anti-infective Vaccines Market Share Forecast by Product, 2022 & 2032 (%)
Figure 60 North America Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million)
Figure 61 North America Anti-infective Vaccines Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 62 U.S. Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 63 Canada Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 64 Europe Anti-infective Vaccines Market Attractiveness Index
Figure 65 Europe Anti-infective Vaccines Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 66 Europe Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million)
Figure 67 Europe Anti-infective Vaccines Market Share Forecast by Country, 2022 & 2032 (%)
Figure 68 Europe Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million)
Figure 69 Europe Anti-infective Vaccines Market Share Forecast by Disease Type, 2022 & 2032 (%)
Figure 70 Europe Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million)
Figure 71 Europe Anti-infective Vaccines Market Share Forecast by Bacterial Diseases, 2022 & 2032 (%)
Figure 72 Europe Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million)
Figure 73 Europe Anti-infective Vaccines Market Share Forecast by Viral Diseases, 2022 & 2032 (%)
Figure 74 Europe Anti-infective Vaccines Market Forecast by Product, 2022-2032 (US$ million)
Figure 75 Europe Anti-infective Vaccines Market Share Forecast by Product, 2022 & 2032 (%)
Figure 76 Europe Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million)
Figure 77 Europe Anti-infective Vaccines Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 78 Germany Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 79 UK Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 80 France Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 81 Italy Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 82 Spain Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 83 Russia Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 84 Rest of Europe Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 85 Asia Pacific Anti-infective Vaccines Market Attractiveness Index
Figure 86 Asia Pacific Anti-infective Vaccines Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 87 Asia Pacific Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million)
Figure 88 Asia Pacific Anti-infective Vaccines Market Share Forecast by Country, 2022 & 2032 (%)
Figure 89 Asia Pacific Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million)
Figure 90 Asia Pacific Anti-infective Vaccines Market Share Forecast by Disease Type, 2022 & 2032 (%)
Figure 91 Asia Pacific Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million)
Figure 92 Asia Pacific Anti-infective Vaccines Market Share Forecast by Bacterial Diseases, 2022 & 2032 (%)
Figure 93 Asia Pacific Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million)
Figure 94 Asia Pacific Anti-infective Vaccines Market Share Forecast by Viral Diseases, 2022 & 2032 (%)
Figure 95 Asia Pacific Anti-infective Vaccines Market Forecast by Product, 2022-2032 (US$ million)
Figure 96 Asia Pacific Anti-infective Vaccines Market Share Forecast by Product, 2022 & 2032 (%)
Figure 97 Asia Pacific Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million)
Figure 98 Asia Pacific Anti-infective Vaccines Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 99 Japan Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 100 China Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 101 India Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 102 Australia Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 103 Rest of Asia Pacific Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 104 Latin America Anti-infective Vaccines Market Attractiveness Index
Figure 105 Latin America Anti-infective Vaccines Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 106 Latin America Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million)
Figure 107 Latin America Anti-infective Vaccines Market Share Forecast by Country, 2022 & 2032 (%)
Figure 108 Latin America Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million)
Figure 109 Latin America Anti-infective Vaccines Market Share Forecast by Disease Type, 2022 & 2032 (%)
Figure 110 Latin America Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million)
Figure 111 Latin America Anti-infective Vaccines Market Share Forecast by Bacterial Diseases, 2022 & 2032 (%)
Figure 112 Latin America Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million)
Figure 113 Latin America Anti-infective Vaccines Market Share Forecast by Viral Diseases, 2022 & 2032 (%)
Figure 114 Latin America Anti-infective Vaccines Market Forecast by Product, 2022-2032 (US$ million)
Figure 115 Latin America Anti-infective Vaccines Market Share Forecast by Product, 2022 & 2032 (%)
Figure 116 Latin America Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million)
Figure 117 Latin America Anti-infective Vaccines Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 118 Brazil Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 119 Mexico Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 120 Rest of Latin America Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 121 MEA Anti-infective Vaccines Market Attractiveness Index
Figure 122 MEA Anti-infective Vaccines Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 123 MEA Anti-infective Vaccines Market Forecast by Country, 2022-2032 (US$ million)
Figure 124 MEA Anti-infective Vaccines Market Share Forecast by Country, 2022 & 2032 (%)
Figure 125 MEA Anti-infective Vaccines Market Forecast by Disease Type, 2022-2032 (US$ million)
Figure 126 MEA Anti-infective Vaccines Market Share Forecast by Disease Type, 2022 & 2032 (%)
Figure 127 MEA Anti-infective Vaccines Market Forecast by Bacterial Diseases, 2022-2032 (US$ million)
Figure 128 MEA Anti-infective Vaccines Market Share Forecast by Bacterial Diseases, 2022 & 2032 (%)
Figure 129 MEA Anti-infective Vaccines Market Forecast by Viral Diseases, 2022-2032 (US$ million)
Figure 130 MEA Anti-infective Vaccines Market Share Forecast by Viral Diseases, 2022 & 2032 (%)
Figure 131 MEA Anti-infective Vaccines Market Forecast by Product, 2022-2032 (US$ million)
Figure 132 MEA Anti-infective Vaccines Market Share Forecast by Product, 2022 & 2032 (%)
Figure 133 MEA Anti-infective Vaccines Market Forecast by Distribution Channel, 2022-2032 (US$ million)
Figure 134 MEA Anti-infective Vaccines Market Share Forecast by Distribution Channel, 2022 & 2032 (%)
Figure 135 GCC Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 136 South Africa Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 137 Rest of MEA Anti-infective Vaccines Market Forecast, 2022-2032 (US$ million)
Figure 138 AstraZeneca: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 139 AstraZeneca: Regional Market Shares, 2021
Figure 140 AstraZeneca: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 141 AstraZeneca: R&D, 2016-2021 (US$ million, AGR %)
Figure 142 Bavarian Nordic: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 143 Bavarian Nordic: Regional Market Shares, 2021
Figure 144 Bavarian Nordic: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 145 Bavarian Nordic: R&D, 2016-2021 (US$ million, AGR %)
Figure 146 CSL Limited: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 147 CSL Limited: Regional Market Shares, 2021
Figure 148 CSL Limited: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 149 CSL Limited: R&D, 2016-2021 (US$ million, AGR %)
Figure 150 Emergent BioSolutions Inc.: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 151 Emergent BioSolutions Inc.: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 152 Emergent BioSolutions Inc.: R&D, 2016-2021 (US$ million, AGR %)
Figure 153 Evotec: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 154 Evotec: Regional Market Shares, 2021
Figure 155 Evotec: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 156 Evotec: R&D, 2016-2021 (US$ million, AGR %)
Figure 157 Merck & Co, Inc.: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 158 Merck & Co, Inc.: Regional Market Shares, 2021
Figure 159 Merck & Co, Inc.: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 160 Merck & Co, Inc.: R&D, 2016-2021 (US$ million, AGR %)
Figure 161 Pfizer: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 162 Pfizer: Regional Market Shares, 2021
Figure 163 Pfizer: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 164 Pfizer: R&D, 2016-2021 (US$ million, AGR%)
Figure 165 Sinovac Biotech Ltd.: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 166 Sinovac Biotech Ltd.: Gross Profit, 2016-2021 (US$ million, AGR %)
Figure 167 Sinovac Biotech Ltd.: R&D, 2016-2021 (US$ million, AGR %)
Figure 168 Valneva SE: Net Revenue, 2016-2021 (US$ million, AGR %)
Figure 169 Global Anti-infective Vaccines Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR %)
Figure 170 Global Anti-infective Vaccines Market Share Forecast by Region 2022, 2027, 2032 (%)